Analytical Testing

Inotiv, Inc. & Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics & Biomarkers

Inotiv, Inc. and Synexa Life Sciences recently announced they intend to form a collaboration that will accelerate Inotiv’s development of biomarkers essential to the understanding of safety and efficacy of novel biotherapeutics, enhancing the….

Ascendia Pharmaceuticals Secures Growth Equity Investment From Signet Healthcare Partners

Ascendia Pharmaceuticals, Inc. is a specialty CDMO dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical-stage drug candidates, and marketed drug products. The investment was made by Signet Healthcare Partners….

Frequently Asked Questions About Analytical Testing

What are the latest trends in analytical testing for pharmaceuticals?

Recent trends include advanced automation in lab processes, predictive in silico modeling, and the adoption of diverse analytical techniques to support evolving biologics, inhaled therapies, and personalized medicines.

How are CDMOs improving resilience in analytical supply chains?

CDMOs are using multi-sourcing strategies, expanding vendor bases, and implementing flexible automation solutions to mitigate risks related to material shortages, tariffs, and geopolitical disruptions.

What role does automation play in modern analytical labs?

Automation solutions—such as semi-automated inhaled product testing and plug‑and‑play instruments—are enhancing accuracy, efficiency, and agility in testing workflows.